Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome

[1]  C. Hoogenraad,et al.  The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies , 2019, Brain : a journal of neurology.

[2]  A. Murray,et al.  The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders , 2019, Journal of Neuroimmunology.

[3]  J. Wymer,et al.  Paraneoplastic Lambert–Eaton Myasthenic Syndrome With Limbic Encephalitis: Clinical Correlation With the Coexistence of Anti-VGCC and Anti-GABAB Receptor Antibodies , 2017, Journal of clinical neuromuscular disease.

[4]  Dong Zhou,et al.  Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission , 2017, Neurological research.

[5]  B. Lang,et al.  Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome , 2017, Neurology.

[6]  C. Klein,et al.  P/Q‐ and N‐type calcium‐channel antibodies: Oncological, neurological, and serological accompaniments , 2016, Muscle & nerve.

[7]  F. Chiou-Tan,et al.  Repetitive nerve stimulation and single‐fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert–Eaton myasthenic syndrome: Review of recent literature , 2015, Muscle & nerve.

[8]  C. Chapman,et al.  Paraneoplastic neurologic disorders in small cell lung carcinoma , 2015, Neurology.

[9]  F. Woermann,et al.  Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  C. Bien,et al.  Conjoint occurrence of GABAB receptor antibodies in Lambert–Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel , 2014, Journal of Neuroimmunology.

[11]  C. Klein,et al.  Neural Autoantibody Clusters Aid Diagnosis of Cancer , 2014, Clinical Cancer Research.

[12]  R. Hubbard,et al.  Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit , 2014, PloS one.

[13]  Romana Höftberger,et al.  Encephalitis and GABAB receptor antibodies , 2013, Neurology.

[14]  J. Britton,et al.  GABAB receptor autoantibody frequency in service serologic evaluation , 2013, Neurology.

[15]  M. Brodie,et al.  Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy , 2013, Epilepsia.

[16]  E. Benarroch,et al.  GABAB receptors , 2012, Neurology.

[17]  J. Verschuuren,et al.  Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies , 2011, The Lancet Neurology.

[18]  J. G. van Dijk,et al.  Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. Dalmau,et al.  GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders , 2011, Neurology.

[20]  P. Boyle,et al.  Clinical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Jan P van Meerbeeck,et al.  Small-cell lung cancer , 1980, The Lancet.

[22]  Andrea Murray,et al.  Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals , 2010, Clinical Cancer Research.

[23]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[24]  J. Robertson,et al.  Technical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  D. Friedman,et al.  Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.

[26]  A. Twijnstra,et al.  SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  J. Verschuuren,et al.  Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Shin J Oh,et al.  Electrophysiological diagnostic criteria of Lambert–Eaton myasthenic syndrome , 2005, Muscle & nerve.

[29]  M. Benatar,et al.  Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line , 2001, Journal of Neuroimmunology.

[30]  D. Jäger,et al.  Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Jacqueline Palace,et al.  Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome , 1997, Journal of the Neurological Sciences.

[32]  N. Murray,et al.  The Lambert-Eaton myasthenic syndrome. A review of 50 cases. , 1988, Brain : a journal of neurology.